Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
Clinical trial NCT05403385 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05403385
- Sponsor
- iTeos Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2025-06-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.